Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Carver, Alissa R ^a   Andrikopoulou, Maria ^b   Lei, Jun ^b   Tamayo, Esther ^a   Gamble, Phyllis ^a   Hou, Zhipeng ^b   Zhang, Jiangyang ^b   Mori, Susumu ^b   Saade, George R ^a   Costantine, Maged M ^a   Burd, Irina ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G2; PRAVASTATIN; VASCULOTROPIN RECEPTOR 1; WATER; FLT1 PROTEIN, MOUSE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN SIZE; BRAIN VENTRICLE; CELL COUNT; CONTROLLED STUDY; CYTOCHEMISTRY; DISEASE MODEL; DRUG EFFECT; FEMALE; FETUS DEVELOPMENT; GLOBUS PALLIDUS; GRAY MATTER; HABENULOINTERPEDUNCULAR TRACT; HIPPOCAMPAL FIMBRIA; INFERIOR COLLICULUS; MALE; MATERNAL TREATMENT; MOTOR PERFORMANCE; MOUSE; MOUSE MODEL; NEOCORTEX; NERVE TRACT; NEUROIMAGING; NISSL STAINING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTIVE DISCRIMINATION; PERIAQUADUCTAL GRAY; PREECLAMPSIA; PROGENY; SPATIAL DISCRIMINATION; STRIA MEDULLARIS; THALAMUS; WEANING; ANIMAL; BRAIN; BRAIN MAPPING; CYTOLOGY; DRUG EFFECTS; ENZYME IMMUNOASSAY; FETUS; GENETICS; IMAGE PROCESSING; METABOLISM; PATHOLOGY; PRE-ECLAMPSIA; PREGNANCY;

ANIMALS; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; FEMALE; FETAL DEVELOPMENT; FETUS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MAGNETIC RESONANCE IMAGING; MALE; MICE; PRAVASTATIN; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84903515558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100873     Document Type: Article

References (84)

1. American College of Obstetricians and Gynecologists (2002) Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. Obstet Gynecol 99: 159-167.
2. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592-1594. (Pubitemid 40807500)
3. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683. (Pubitemid 38364626)
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5): 649-658.
5. Lu F, Bytautiene E, Tamayo E, Gamble P, Anderson GD, et al. (2007) Gender-specific effect of over-expression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol 197: 418e1-418e5.
6. Lu F, Longo M, Tamayo, Maner W, Al-Hendy A, et al. (2007) The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 196(4): 396.e1-7.
7. Costantine M, Rea CH, Tamayo E, Ghulmiyyah LM, Wen T, et al. (2008) Susceptibility to hypoxic-ischemic (HI) injury in rat pups born to mothers with preeclampsia induced by sFlt-1 overexpression. Am J Obstet Gynecol 199(6): S40.
8. Carver AR, Tamayo E, Perez-Polo JR, Saade GR, Hankins GD, et al. (2014) The effect of maternal pravastatin therapy on adverse sensorimotor outcomes of the offspring in a murine model of preeclampsia. Int J Dev Neurosci 33: 33-40.
9. Ehrenstein V, Rothman KJ, Pederson L, Hatch EE, Sorensen HT (2009) Pregnancy-associated hypertensive disorders and adult cognitive function among Danish conscripts. Am J Epidemiol 170(8): 1025-1031.
10. Many A, Fattal A, Leitner Y, Kupfermine MJ, Harel S, et al. (2003) Neurodevelopmental and cognitive assessment of children born growth restricted to mothers with and without preeclampsia. Hypertens Pregnancy 22(1): 25-29. (Pubitemid 36205805)
11. Mann JR, McDermott S, Bao H, Hardin J, Gregg A (2010) Pre-eclampsia, birth weight, and autism spectrum disorders. J Autism Dev Disord 40: 548-554.
12. Mann JR, McDermott S (2011) Are maternal genitourinary infection and preeclampsia associated with ADHD in school-aged children? J Atten Disord 15(8): 667-673.
13. van Wassenaer AG, Westera J, van Schie PEM, Houtzager BA, Cranendonk A, et al. (2011) Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy. Amer J Obstet Gynecol 204: 510.e1-9.
14. Whitehouse AJ, Robinson M, Newnham JP, Pennell CE (2012) Do hypertensive diseases of pregnancy disrupt neurocognitive development in offspring? Paediatr Perinat Epidemiol 26(2): 101-108.
15. Costantine MM, Tamayo E, Lu F, Bytautiene E, Longo M, et al. (2010) Using pravastatin to improve the vascular reactivity in a mouse model of soluble Fmslike tyrosine kinase-1-induced preeclampsia. Obstet Gynecol 116(1): 114-120.
16. Fox KA, Longo M, Tamayo E, Kechichian T, Bytautiene E, et al. (2011) Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol 205: 366.e1-5.
17. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, et al. (2011) Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci USA 108(4): 1451-1455.
18. Saad AF, Kechichian T, Yin H, Sbrana E, Longo M, et al. (2014) Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reprod Sci. 21(1): 138-145.
19. Singh J, Ahmed A, Girardi G (2011) Role of complement component C1q in the onset of preeclampsia in mice. Hypertension 58(4): 716-724.
20. Zhang J, Peng Q, Li Q, Jahanshad N, Hou Z, et al. (2010) Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images. Neuroimage 49(3): 2340-2351.
21. nd ed. San Diego: El Sevier Academic Press. 296 p.
22. Chau V, Synnes A, Grunau RE, Poskitt KJ, Brant R, et al. (2013) Abnormal brain maturation in preterm neonates associated with adverse developmental outcomes. Neurology 81(24): 2082-2089.
23. Brosda J, Dietz F, Koch M (2011) Impairment of cognitive performance after reelin knockdown in the medial prefrontal cortex of pubertal or adult rats. Neurobiol Dis 44(2): 239-247.
24. Folsom TD, Fatemi SH (2013) The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68: 122-135.
25. Dada T, Rosenzweig JM, Al Shammary M, Firdaus W, Al Rebh S, et al. (2014) Mouse model of intrauterine inflammation: Sex-specific differences in long-term neurologic and immune sequelae. Brain Behav Immun 38: 142-150.
26. Golan MH, Mane R, Molczadzki G, Zuckerman M, Kaplan-Louson V, et al. (2009) Impaired migration signaling in the hippocampus following prenatal hypoxia. Neuropharmacology 57(5-6): 511-522.
27. Bytautiene E, Lu F, Tamayo EH, Hankins GDV, Longo M, et al. (2010) Longterm maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol 298: H189-H193.
28. Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008) Effect of in-utero and early-life conditions on adult health and disease. N Engl J Med 359(1): 61-73.
29. Machon RA, Mednick SA, Huttunen MO (1997) Adult major affective disorder after prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 54(4): 322-328. (Pubitemid 27171917)
30. Liao JK (2005) Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96(5A): 24F-33F.
31. Mooradian AD, Haas MJ, Batejko O, Hovsepyan M, Feman SS (2005) Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 54(10): 2977-2982. (Pubitemid 41401095)
32. Sacco RL, Liao JK (2005) Drug insight: statins and stroke. Nat Clin Pract Cardiovasc Med 2(11): 576-584. (Pubitemid 41655661)
33. Elahi MM, Cagampang FR, Anthony FW, Curzen N, Ohri SK, et al. (2008) Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring. Hypertension 51(4): 939-944. (Pubitemid 351654708)
34. Hoglund K, Blennow K (2007) Effect of HMG-CoA Reductase Inhibitors on bamyloid peptide levels: implications for Alzheimer's disease. CNS Drugs 21(6): 449-462. (Pubitemid 46849181)
35. Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J (2012) Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. Brain Res 1471: 13-22.
36. Li A, Lv S, Yu Z, Zhang Y, Ma H, et al. (2010) Simvastatin attenuates hypomyelination induced by hypoxia-ischemia in rats. Neurol Res 32(9): 945-952.
37. Mahmood A, Goussev A, Kazmi H, Qu C, Lu D, et al. (2009) Long-term benefits after treatment of traumatic brain injury with simvastatin in rats. Neurosurgery 65(1): 187-192.
38. Paintlia AS, Paintlia MK, Singh I, Skoff RB, Singh AK (2009) Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis. Glia 57(2): 182-193.
39. Wei K, Kuhnert F, Kuo CJ (2007) Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways. J Mol Med 86(2): 161-169.
40. Chagraoui H, Giraudier S, Vainchenker W, Wendling F (2001) Adenoviral supply of active transforming growth factor-beta 1 (TGF-beta1) did not prevent lethality in transforming growth factor-beta1-knockout embryos. Eur Cytokine Netw 12(4): 561-567. (Pubitemid 34062142)
41. Senoo M, Matsubara Y, Fujii K, Nagasaki Y, Hiratsuka M, et al. (2000) Adenovirus-mediated in utero gene transfer in mice and guinea pigs: tissue distribution of recombinant adenovirus determined by quantitative Taqmanpolymerase chain reaction assay. Mol Genet Metab 69(4): 269-276. (Pubitemid 30333661)
42. Kikuchi N, Nakamura S, Ohtsuka M, Kimura M, Sato M (2002) Possible mechanism of gene transfer into early to mid-gestational mouse fetuses by tail vein injection. Gene Ther 9(22): 1529-1541. (Pubitemid 35414788)
43. Davies LA, Varathalingam A, Painter H, Lawton AE, Sumner-Jones SG, et al. (2008) Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol Ther 16(5): 812-818. (Pubitemid 351587088)
44. Hatanaka T (2000) Clinical pharmacokinetics of pravastatin. Clin Pharmacokinet 39(6): 397-412.
45. Kikuchi R, Kusuhara H, Abe T, Endou H, Sugiyama Y (2004) Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier. J Pharmacol Exp Ther 311(3): 1147-1153. (Pubitemid 39612722)
46. Nanovskaya TN, Patrikeeva SL, Paul J, Costantine MM, Hankins GDV, et al. (2013) Transplacental transfer and distribution of pravastatin. Am J Obstet Gynecol 209(4): 373.e1-5.
47. Sierra S, Ramos MC, Molina P, Esteo C, Vasquez JA, et al. (2011) Statins as neuroprotectants: A comparative in vitro study of lipophilicity, blood-brain barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis 23(2): 307-318.
48. Zarek J, DeGorter MK, Lubetsky A, Kim RB, Laskin CA, et al. (2013) The transfer of pravastatin in the dually perfused human placenta. Placenta 34(8): 719-721.
49. Cassell JC, Duconseille E, Jeltsch H, Will B (1997) The fimbria-fornix/cingular bundle pathways: A review of neurochemical and behavioral approaches using lesions and transplantation techniques. Prog Neurobiol 51(6): 663-716. (Pubitemid 27244541)
50. Gebhart GF (2004) Descending modulation of pain. Neurosci Biobehav Rev 27(8): 729-737.
51. Bajo VM, King AJ (2013) Cortical modulation of auditory processing in the midbrain. Front Neural Circuits 6:114.
52. Prevosto V, Sommer MA (2013) Cognitive control of movement via the cerebella-recipient thalamus. Front Syst Neurosci 7: 56.
53. Klooster J, Vrensen GF, Muller LJ, van der Want JJ (1995) Efferent projections of the olivary pretectal nucleus in the albino rat subserving the pupillary light reflex and related reflexes. A light microscopic tracing study. Brain Res 688(1-2): 34-46.
54. Paul MJ, Indic P, Schwartz WJ (2011) A role for the habenula in the regulation of locomotor activity cycles. Eur J Neurosci 34(3): 478-488.
55. Ellison G (1994) Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res Brain Res Rev 19(2): 223-239.
56. Stephenson-Jones M, Kardamakis AA, Robertson B, Grillner S (2013) Independent circuits in the basal ganglia for the evaluation and selection of actions. Proc Natl Acad Sci USA 110(38): E3670-E3679.
57. Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, et al. (2013) Cerebral atrophy in mild cognitive impairment and Alzheimer disease: Rates and acceleration. Neurology 80(7): 648-654.
58. Movsas TZ, Pinto-Martin JA, Whitaker AH, Feldman JF, Lorenz JM, et al. (2013) Autism spectrum disorder is associated with ventricular enlargement in a low birth weight population. J Pediatr 163(1): 73-78.
59. Wilde EA, Hunter JV, Newsome MR, Scheibel RS, Bigler ED, et al. (2005) Frontal and temporal morphometric findings on MRI in children after moderate to severe traumatic brain injury. J Neurotrauma 22(3): 333-344. (Pubitemid 40434682)
60. Beckmann H (1999) Developmental malformations in cerebral structures of schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 249 Suppl 4: 44-47.
61. Huang H, Shu N, Mishra V, Jeon T, Chalak L, et al. (2013) Development of brain structural networks through infancy and childhood. Cereb Cortex (In press).
62. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, et al. (2014) Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci 17(3): 400-406.
63. Ingalhalikar M, Smith A, Parker D, Satterthwaite TD, Elliott MA, et al. (2014) Sex differences in the structural connectome of the human brain. Proc Natl Acad Sci USA 111(2): 823-828.
64. Peacock JL, Marston L, Marlow N, Calvert SA, Greenough A (2012) Neonatal and infant outcome in boys and girls born very prematurely. Pediatr Res 7(3): 305-310.
65. Suren P, Bakken IJ, Aase H, Chin R, Gunnes N, et al. (2012) Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children. Pediatrics 130(1): e152-158.
66. Hill CA, Fitch RH (2012) Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol Res Int 2012:867531.
67. Infante SK, Rea HC, Perez-Polo JR (2013) Transgenerational effects of neonatal hypoxia-ischemia in progeny. Int J Dev Neurosci 31(6): 398-405.
68. Gabory A, Roseboom TJ, Moore T, Moore LG, Junien C (2013) Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics. Biol Sex Differ 4(1): 5.
69. Wagner AK, Fabio A, Puccio AM, Hirschberg R, Li W, et al. (2005) Gender associations with cerebrospinal fluid glutamate and lactate/pyruvate levels after severe traumatic brain injury. Crit Care Med 33(2): 407-413. (Pubitemid 40216556)
70. McCarthy MM, Auger AP, Bale TL, De Vries GJ, Dunn GA, et al. (2009) The epigenetics of sex differences in the brain. J Neurosci 29(41): 12815-12823.
71. Herson PS, Palmateer J, Hurn PD (2013) Biological sex and mechanisms of ischemic brain injury. Transl Stroke Res 4(4): 413-419.
72. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, et al. (2006) Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem 96(4): 1016-1027.
73. Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, et al. (2005) Sex differences in cell death. Ann Neurol 58(2): 317-321. (Pubitemid 41098890)
74. Bushnell CD, Griffin J, Newby LK, Goldstein LB, Mahaffey KW, et al. (2006) Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 37(6): 1427-1431. (Pubitemid 44305721)
75. Gutierrez J, Ramirez G, Rundek T, Sacco RL (2012) Statin therapy in prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med 172(12):909-919.
76. McDonnold M, Tamayo E, Kechichian T, Urrabaz-Garza R, Longo M, et al. (2013) The effect of prenatal pravastatin treatment on altered fetal programming of cardiovascular function in a preeclampsia-like murine model. Am J Obstet Gynecol 208(1): S28-S29.
77. McDonnold M, Tamayo E, Kechichian T, Gamble P, Longo M, et al. (2014) The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol 210(6): 542.e1-e7.
78. Costantine MM, Cleary K, Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric - Fetal Pharmacology Research Units Network (2013) Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol 121(2 Pt 1): 349-353.
79. Edison RJ, Muenke M (2004) Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Gen 131A: 287-298.
80. Kazmin A, Garcia-Bournissen F, Koren (2007) Risk of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can. 29(11): 906-908.
81. Ofori B, Rey E, Berard A (2007) Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol 64(4): 496-509. (Pubitemid 47404298)
82. Taguchi N, Rubin ET, Hosokawa A, Choi J, Ying AY, et al. (2008) Prenatal exposure to HMG-CoA reductase inhibitor: effects on fetal and neonatal outcomes. Repro Tox 26(2): 175-177.
83. Peterson EE, Mitchell AA, Carey JC, Werler MM, Louik C, et al. (2008) Maternal exposure to statins and risk for birth defects: a case series approach. Am J Med Gen 146A(20): 2701-2705.
84. Winterfield U, Allignol A, Panchaud A, Rothuizen LE, Merlob P, et al. (2013) Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG 120(4): 463-471. Development